Volume 29, Number 5, 411-413, DOI: 10.1007/s10792-008-9237-z

Published in partnership with the

Logo

Society for Ophthalmo-Immuno Infectiology in Europe

Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection

Hisham S. Alkuraya, Abdullah S. Al-kharashi, Essam Alharthi and Imtiaz A. Chaudhry

View Related Documents

Abstract

Purpose To report a case of culture-positive endophthalmitis after intravitreal injection of bevacizumab (Avastin) resulting in a devastating visual outcome. Method A retrospective case report of a 51-year-old diabetic women who presented with further decrease in her vision, redness, and mild pain in her eye 3 days after intravitreal injection of Avastin for macular edema due to a branch retinal vein occlusion. Results Clinical diagnosis of endophthalmitis was made and, after obtaining a vitreous tap, intravitreal antibiotics were administered. Because of worsening of the endophthalmitis, pars plana vitrectomy was undertaken followed by repeat intravitreal antibiotics injection. The patient’s ocular condition improved dramatically; however, her visual acuity did not improve. The cultures from vitreous taps revealed Staphylococcus lugdunesis. Conclusion Intravitreal injection of Avastin may be associated with a risk of S. lugdunesis-caused endophthalmitis which can have a devastating effect on the final visual outcome.

Keywords  Endophthalmitis - Avastin - Bevacizumab -  Staphylococcus lugdunesis

Fulltext Preview

Image of the first page of the fulltext document